JP2015221806A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015221806A5 JP2015221806A5 JP2015133015A JP2015133015A JP2015221806A5 JP 2015221806 A5 JP2015221806 A5 JP 2015221806A5 JP 2015133015 A JP2015133015 A JP 2015133015A JP 2015133015 A JP2015133015 A JP 2015133015A JP 2015221806 A5 JP2015221806 A5 JP 2015221806A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- dosage form
- oral dosage
- pharmaceutically acceptable
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83633406P | 2006-08-08 | 2006-08-08 | |
| US60/836,334 | 2006-08-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012239767A Division JP2013047257A (ja) | 2006-08-08 | 2012-10-31 | ヒトの血小板レベルを増加させるための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015221806A JP2015221806A (ja) | 2015-12-10 |
| JP2015221806A5 true JP2015221806A5 (enExample) | 2016-06-30 |
| JP6258264B2 JP6258264B2 (ja) | 2018-01-10 |
Family
ID=39082656
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009523867A Pending JP2010500361A (ja) | 2006-08-08 | 2007-08-08 | ヒトの血小板レベルを増加させるための組成物および方法 |
| JP2012239767A Withdrawn JP2013047257A (ja) | 2006-08-08 | 2012-10-31 | ヒトの血小板レベルを増加させるための組成物および方法 |
| JP2015133015A Active JP6258264B2 (ja) | 2006-08-08 | 2015-07-01 | ヒトの血小板レベルを増加させるための組成物および方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009523867A Pending JP2010500361A (ja) | 2006-08-08 | 2007-08-08 | ヒトの血小板レベルを増加させるための組成物および方法 |
| JP2012239767A Withdrawn JP2013047257A (ja) | 2006-08-08 | 2012-10-31 | ヒトの血小板レベルを増加させるための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20080039475A1 (enExample) |
| EP (2) | EP2056826B1 (enExample) |
| JP (3) | JP2010500361A (enExample) |
| AU (2) | AU2007284644B2 (enExample) |
| CA (1) | CA2660283C (enExample) |
| ES (2) | ES2452032T3 (enExample) |
| IL (4) | IL196897A (enExample) |
| WO (1) | WO2008021283A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1466912E (pt) * | 2002-01-18 | 2013-06-28 | Astellas Pharma Inc | Derivado de 2-aciloaminotiazol ou seu sal |
| WO2011019990A1 (en) * | 2009-08-14 | 2011-02-17 | Eisai, Inc. | Use of e5501 for stimulating platelet production |
| CN112022825B (zh) * | 2020-08-24 | 2024-03-22 | 瑞阳制药股份有限公司 | 马来酸阿伐曲泊帕片剂及其制备方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5330998A (en) * | 1988-03-08 | 1994-07-19 | Pfizer Inc. | Thiazolidinedione derivatives as hypoglycemic agents |
| US5256675A (en) * | 1989-08-07 | 1993-10-26 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same |
| IE68593B1 (en) * | 1989-12-06 | 1996-06-26 | Sanofi Sa | Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them |
| FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
| US5250732A (en) * | 1991-07-18 | 1993-10-05 | Genentech, Inc. | Ketamine analogues for treatment of thrombocytopenia |
| GB9126677D0 (en) * | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| EP0620403B1 (de) * | 1993-04-08 | 1996-12-04 | ABB Management AG | Misch- und Flammenstabilisierungseinrichtung in einer Brennkammer mit Vormischverbrennung |
| DE69629341T2 (de) * | 1995-03-09 | 2004-06-09 | Kyowa Hakko Kogyo Co., Ltd. | Pyrrolocarbazolderivate |
| KR19990008109A (ko) * | 1995-04-28 | 1999-01-25 | 나가사까 겐지로 | 1,4-이치환 피페리딘 유도체 |
| CN1966520B (zh) * | 1995-06-07 | 2012-07-11 | 葛兰素集团有限公司 | 结合血小板生成素受体的肽和化合物 |
| US5963666A (en) * | 1995-08-18 | 1999-10-05 | International Business Machines Corporation | Confusion matrix mediated word prediction |
| DE69626624T2 (de) * | 1995-10-17 | 2003-11-27 | Daiichi Suntory Pharma Co., Ltd. | Medikamente gegen trhombocytopenie |
| US5932546A (en) * | 1996-10-04 | 1999-08-03 | Glaxo Wellcome Inc. | Peptides and compounds that bind to the thrombopoietin receptor |
| US6187797B1 (en) * | 1996-12-23 | 2001-02-13 | Dupont Pharmaceuticals Company | Phenyl-isoxazoles as factor XA Inhibitors |
| AU762245B2 (en) * | 1998-09-18 | 2003-06-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
| EP1133291B1 (en) * | 1998-11-17 | 2006-01-11 | Smithkline Beecham Corporation | Cyclic polyamines for treating thrombocytopenia |
| TWI284639B (en) * | 2000-01-24 | 2007-08-01 | Shionogi & Co | A compound having thrombopoietin receptor agonistic effect |
| GB0028383D0 (en) * | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| JPWO2002062775A1 (ja) * | 2001-02-02 | 2004-06-10 | 山之内製薬株式会社 | ２−アシルアミノチアゾール誘導体又はその塩 |
| WO2002062792A1 (en) * | 2001-02-02 | 2002-08-15 | Takeda Chemical Industries, Ltd. | Jnk inhibitor |
| PT1466912E (pt) * | 2002-01-18 | 2013-06-28 | Astellas Pharma Inc | Derivado de 2-aciloaminotiazol ou seu sal |
| CA2744893A1 (en) * | 2002-06-27 | 2004-01-08 | Novo Nordisk A/S | Aryl carbonyl derivatives as glucokinase activators |
| WO2004029049A1 (ja) * | 2002-09-30 | 2004-04-08 | Yamanouchi Pharmaceutical Co., Ltd. | 2-アシルアミノチアゾール誘導体の新規な塩 |
| JP2006524688A (ja) * | 2003-03-25 | 2006-11-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なチアゾール |
| JP4324791B2 (ja) * | 2003-07-17 | 2009-09-02 | アステラス製薬株式会社 | ２−アシルアミノチアゾール誘導体又はその塩 |
| KR100776961B1 (ko) * | 2003-08-12 | 2007-11-28 | 시오노기세이야쿠가부시키가이샤 | 트롬보포이에틴 수용체 아고니스트 작용을 가지는 화합물 |
| WO2007054783A2 (en) * | 2005-11-08 | 2007-05-18 | Astellas Pharma Inc. | Compositions and methods for treating thrombocytopenia |
-
2007
- 2007-08-08 ES ES07811274.5T patent/ES2452032T3/es active Active
- 2007-08-08 WO PCT/US2007/017860 patent/WO2008021283A2/en not_active Ceased
- 2007-08-08 US US11/891,133 patent/US20080039475A1/en not_active Abandoned
- 2007-08-08 EP EP07811274.5A patent/EP2056826B1/en active Active
- 2007-08-08 ES ES11190964.4T patent/ES2470333T3/es active Active
- 2007-08-08 CA CA2660283A patent/CA2660283C/en active Active
- 2007-08-08 JP JP2009523867A patent/JP2010500361A/ja active Pending
- 2007-08-08 AU AU2007284644A patent/AU2007284644B2/en active Active
- 2007-08-08 EP EP11190964.4A patent/EP2452674B1/en active Active
-
2009
- 2009-02-04 IL IL196897A patent/IL196897A/en active IP Right Grant
-
2011
- 2011-03-31 US US13/077,736 patent/US20110224226A1/en not_active Abandoned
- 2011-12-01 AU AU2011253775A patent/AU2011253775B2/en active Active
-
2012
- 2012-10-31 JP JP2012239767A patent/JP2013047257A/ja not_active Withdrawn
-
2015
- 2015-07-01 JP JP2015133015A patent/JP6258264B2/ja active Active
- 2015-08-03 IL IL240322A patent/IL240322A0/en unknown
- 2015-08-03 IL IL240323A patent/IL240323A/en active IP Right Grant
-
2016
- 2016-05-29 IL IL245911A patent/IL245911A0/en unknown